A glucose-centric perspective of hyperglycemia

Ramasarma, T and Rafi, M (2016) A glucose-centric perspective of hyperglycemia. In: INDIAN JOURNAL OF EXPERIMENTAL BIOLOGY, 54 (2). pp. 83-99.

PDF Ind_Jou_Exp_Bio_54-2_83_2016.pdf - Published Version Restricted to Registered users only Download (401kB) | Request a copy

Abstract

Digestion of food in the intestines converts the compacted storage carbohydrates, starch and glycogen, to glucose. After each meal, a flux of glucose (>200 g) passes through the blood pool (4-6 g) in a short period of 2 h, keeping its concentration ideally in the range of 80-120 mg/100 mL. Tissue-specific glucose transporters (GLUTs) aid in the distribution of glucose to all tissues. The balance glucose after meeting the immediate energy needs is converted into glycogen and stored in liver (up to 100 g) and skeletal muscle (up to 300 g) for later use. High blood glucose gives the signal for increased release of insulin from pancreas. Insulin binds to insulin receptor on the plasma membrane and activates its autophosphorylation. This initiates the post-insulin-receptor signal cascade that accelerates synthesis of glycogen and triglyceride. Parallel control by phos-dephos and redox regulation of proteins exists for some of these steps. A major action of insulin is to inhibit gluconeogensis in the liver decreasing glucose output into blood. Cases with failed control of blood glucose have alarmingly increased since 1960 coinciding with changed life-styles and large scale food processing. Many of these turned out to be resistant to insulin, usually accompanied by dysfunctional glycogen storage. Glucose has an extended stay in blood at 8 mM and above and then indiscriminately adds on to surface protein-amino groups. Fructose in common sugar is 10-fold more active. This random glycation process interferes with the functions of many proteins (e.g., hemoglobin, eye lens proteins) and causes progressive damage to heart, kidneys, eyes and nerves. Some compounds are known to act as insulin mimics. Vanadium-peroxide complexes act at post-receptor level but are toxic. The fungus-derived 2,5-dihydroxybenzoquinone derivative is the first one known to act on the insulin receptor. The safe herbal products in use for centuries for glucose control have multiple active principles and targets. Some are effective in slowing formation of glucose in intestines by inhibiting alpha-glucosidases (e.g., salacia/saptarangi). Knowledge gained from French lilac on active guanidine group helped developing Metformin (1,1-dimethylbiguanide) one of the popular drugs in use. One strategy of keeping sugar content in diets in check is to use artificial sweeteners with no calories, no glucose or fructose and no effect on blood glucose (e.g., steviol, erythrytol). However, the three commonly used non-caloric artificial sweetener's, saccharin, sucralose and aspartame later developed glucose intolerance, the very condition they are expected to evade. Ideal way of keeping blood glucose under 6 mM and HbAlc, the glycation marker of hemoglobin, under 7% in blood is to correct the defects in signals that allow glucose flow into glycogen, still a difficult task with drugs and diets.

Item Type:	Journal Article
Publication:	INDIAN JOURNAL OF EXPERIMENTAL BIOLOGY
Publisher:	NATL INST SCIENCE COMMUNICATION-NISCAIR
Additional Information:	Copy right for this article belongs to the NATL INST SCIENCE COMMUNICATION-NISCAIR, DR K S KRISHNAN MARG, PUSA CAMPUS, NEW DELHI 110 012, INDIA
Keywords:	Diabetes; Dysfunctional glycogen storage; Gluconeogenesis; Glucose intolerance; GLUTs; Herbals in glucose control; Insulin mimics; Post-insulin-receptor signal cascade; Random glycation; Tissue-specific glucose transporters
Department/Centre:	Division of Biological Sciences > Biochemistry
Date Deposited:	19 Mar 2016 07:17
Last Modified:	19 Mar 2016 07:17
URI:	http://eprints.iisc.ac.in/id/eprint/53405

Actions (login required)

View Item